The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats

  • L. Yavich
  • J. Sirviö
  • E. Heinonen
  • P. RiekkinenSr.
Full Papers


L-Deprenyl, a specific MAO-B inhibitor, has been reported to improve learning/memory in some cognitive tests in aged rats. The present study investigated whether L-deprenyl could alleviate the spatial learning deficit induced by muscarinic blockade and aging in OFA rats. Scopolamine (0.25 mg/kg) impaired the acquisition of a water maze task in adult rats and increased their swimming speeds. L-Deprenyl (0.25 mg/kg, 14 days) had no effect on water maze performance in saline treated adult rats, but markedly alleviated the learning deficit induced by scopolamine and increased the time and distance of swimming in the training quadrant when the platform was removed (spatial probe trial). L-Deprenyl partly reduced the effect of scopolamine on speed of swimming. Nevertheless, administration of l-deprenyl (0.25 mg/kg, 14 days) had no effect on spatial learning/memory in aged rats. We suggest that the l-deprenyl-scopolamine interaction in the water maze test may be considered as a premise for further investigations of l-deprenyl as cognition enhancer.


L-deprenyl scopolamine water maze learning memory rat 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agnoli A, Martucci N, Fabbrini G, Buckley AE, Fioravanti M (1990) Monoamine oxidase and dementia: treatment with an inhibitor of MAO-B activity. Dementia 1: 109–114Google Scholar
  2. Barnes CA (1988) Aging and the physiology of spatial memory. Neurobiol Aging 9: 563–568PubMedGoogle Scholar
  3. Bartus RT, Dean RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417Google Scholar
  4. Biegon A, Greenberger V, Segal M (1986) Quantitative histochemistry of brain acetylcholinesterase, and learning rate in the aged rat. Neurobiol Aging 7: 215–217CrossRefPubMedGoogle Scholar
  5. Bischoff S (1986) Mesohippocampal dopamine system: characterisation, functional and clinical implications. In: Isaacson RL, Pribram KH (eds) Hippocampus, vol 3. Plenum Press, New York, pp 1–32Google Scholar
  6. Brandeis R, Sapir M, Kapon Y, Borelli G, Cadel S, Valsecchi B (1991) Improvement of cognitive function by MAO-B inhibitor l-deprenyl in aged rats. Pharmacol Biochem Behav 39: 297–304CrossRefPubMedGoogle Scholar
  7. Consolo S, Girotti P, Russi G, Di Chiara G (1992) Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J Neurochem 59: 1555–1557PubMedGoogle Scholar
  8. Drago F, Continella G, Spadaro F, Cavaliere S, Scapagnini U (1986) Behavioral effects of deprenyl in aged rats. Funct Neurol 2: 165–174Google Scholar
  9. Eichenbaum H, Stewart C, Morris RG (1990) Hippocampal representation in place learning. J Neurosci 10: 3531–3542Google Scholar
  10. Engberg G, Elebring T, Nissbrandt H (1991) Deprenyl (Selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. J Pharmacol Exp Ther 259: 841–847PubMedGoogle Scholar
  11. Gage FN, Bjorklund A (1986) Cholinergic septal grafts into the hippocampal formation improve spatial learning and memory in the aged rats by an atropine-sensitive mechanism. J Neurosci 6: 2837–2847PubMedGoogle Scholar
  12. Gallagher M, Pelleymounter MA (1988) Spatial learning deficits in old rats: a model for memory decline in the aged. Neurobiol Aging 9: 549–556PubMedGoogle Scholar
  13. Gallagher M, Burwell RD, Kodsi MH, McKinney M, Southerland S, Vella-Rountree L Lewis MH (1990) Markers for biogenic amines in the aged rat brain: relationship to decline in spatial learning ability: Neurobiol Aging 11: 507–514CrossRefPubMedGoogle Scholar
  14. Goldman-Rakic PS, Brown RM (1981) Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience 6: 177–187CrossRefPubMedGoogle Scholar
  15. Hårsing LGJ, Magyar K, Tekes K, Visi ES, Knoll J (1979) Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition. Pol J Pharmacol 31: 297–307Google Scholar
  16. Heinonen EH, Myllylä V, Sotaniemi K, Lamintausta R, Salonen JS, Anttila M, Savijärvi M, Kotila M, Rinne UK (1989) Pharmacokinetics and metabolism of selegiline. Acta Neurol Scand 80: 83–91Google Scholar
  17. Heybach JP, Coover GD (1976) Deficient passive and one-way active avoidance acquisition following medial forebrain bundle lesions in rats. J Comp Physiol Psychol 90: 491–504PubMedGoogle Scholar
  18. Kelly J, Alheid GF, McDermott L, Halaris A, Grossman SP (1977) Behavioral and biochemical effects of knife cuts that preferentially interrupt principal afferent and efferent connections of the striatum in the rat. Pharmacol Biochem Behav 6: 31–45CrossRefPubMedGoogle Scholar
  19. Knoll J (1987) R-(−)-Deprenyl (Selegiline, Movergan®) facilitates the activity of the nigrostriatal dopaminergic neuron. J Neural Transm [Suppl 25]: 45–66Google Scholar
  20. Knoll J (1988) Extension of life span of rats by long-term (−) deprenyl treatment. Mt Sinai J Med 55: 67–74PubMedGoogle Scholar
  21. Knoll J (1989) The pharmacology of selegiline ((−)-deprenyl). New aspects. Acta Neurol Scand 126: 83–91Google Scholar
  22. Levin ED (1988) Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats. Behav Neural Biol 50: 240–245CrossRefPubMedGoogle Scholar
  23. Levin ED, Rose JE (1991) Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance. Pharmacol Biochem Behav 38: 243–246CrossRefPubMedGoogle Scholar
  24. Levin ED, McGurk SR, Rose JE, Butcher LL (1990a) Cholinergic-dopaminergic interactions in cognitive performance. Behav Neural Biol 54: 271–299Google Scholar
  25. Levin ED, Rose JE, McGurk SR, Butcher LL (1990b) Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. Behav Neural Biol 53: 103–112CrossRefPubMedGoogle Scholar
  26. Luine V, Bowling D, Hearns M (1990) Spatial memory deficits in aged rats: contributions of monoaminergic systems. Brain Res 537: 271–278CrossRefPubMedGoogle Scholar
  27. Marshall JF, Altar CA (1986) Striatal dopamine uptake and swim performance of aged rat. Brain Res 379: 112–117CrossRefPubMedGoogle Scholar
  28. Martini E, Pataky I, Szilagyi K, Venter V (1987) Brief information on an early phase-II-study with deprenyl in demented patients. Pharmacopsychiatry 20: 256–257PubMedGoogle Scholar
  29. McGurk SR, Levin ED, Butcher LL (1988) Cholinergic-dopaminergic interactions in radial-arm maze performance. Behav Neural Biol 49: 234–239Google Scholar
  30. McGurk SR, Levin ED, Butcher LL (1992) Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway. Neuroscience 50: 129–135CrossRefPubMedGoogle Scholar
  31. McNaughton BL, Barnes CA, Meltzer J, Sutherland RJ (1989) Hippocampal granule cells are necessary for normal spatial learning but not for spatially-selective pyramidal cell discharge. Exp Brain Res 76: 485–496CrossRefPubMedGoogle Scholar
  32. Memo M, Missale C, Trivelli L, Spano PF (1988) Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex. Eur J Pharmacol 149: 367–370CrossRefPubMedGoogle Scholar
  33. Moretti A, Carfagna N, Trunzo F (1987) Effect of aging on monoamines and their metabolites in the rat brain. Neurochem Res 12: 1035–1039CrossRefPubMedGoogle Scholar
  34. Morris R (1984) Developments of a water maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47–60CrossRefPubMedGoogle Scholar
  35. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982) Place navigation impaired in rats with hippocampal lesions. Nature 297: 681–683CrossRefPubMedGoogle Scholar
  36. Packard MG, White NM (1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 105: 295–306Google Scholar
  37. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459PubMedGoogle Scholar
  38. Piccini GL, Finali G, Piccirilli M (1990) Neuropsychological effects of 1-deprenyl in Alzheimer's type dementia. Clin Neuropharmacol 13: 147–163PubMedGoogle Scholar
  39. Ponzio F, Calderini G, Lomuscio G, Vantini G, Toffano G, Algeri S (1982) Changes in monamines and their metabolite levels in some brain regions of aged rats. Neurobiol Aging 3: 23–29CrossRefPubMedGoogle Scholar
  40. Rapp PR, Rosenberg RA, Gallagher M (1987) An evaluation of spatial information processing in aged rats. Behav Neurosci 101: 3–12CrossRefPubMedGoogle Scholar
  41. Piekkinen P Jr, Sirviö J, Aaltonen M, Riekkinen PJ (1990a) Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol Biochem Behav 37: 405–410CrossRefPubMedGoogle Scholar
  42. Riekkinen P Jr, Sirviö J, Riekkinen PJ (1990b) Similar memory impairment found in medial septal-vertical diagonal band of Broca and nucleus basalis lesions rats: are memory deficits induced by nucleus basalis lesions related to the degree of nonspecific subcortical cell loss. Behav Brain Res 37: 81–88CrossRefPubMedGoogle Scholar
  43. Robertson GS, Hubert GW, Tham C-S, Fibiger HC (1992) Lesions of the mesotelencephalic dopamine system enhance the effects of selective dopamine D1 and D2 receptor agonists on striatal acetylcholine release. Eur J Pharmacol 219: 323–325CrossRefPubMedGoogle Scholar
  44. Seliger DL (1975) Dose-response effect of d-amphetamine on passive avoidance learning in the rat. Psychopharmacologia 44: 191–193CrossRefPubMedGoogle Scholar
  45. Sutherland RJ, Whishaw IQ, Kolb B (1983) A behavioural analysis of spatial localization following electrolytic, kainate-, or colchicine-induced damage to the hippocampal formation in the rat. Behav Brain Res 7: 133–153CrossRefPubMedGoogle Scholar
  46. Tariot PN, Cohen MM, Sunderland T, Newhouse PA, Yount D, Mellow AM, Weingartner H, Mueller EA, Murphy DL (1987a) L-Deprenyl in Alzheimer's disease. Arch Gen Psychiatry 44: 427–433PubMedGoogle Scholar
  47. Tariot PN, Sunderland T, Weingartner H, Murphy DL, Welkowitz JA, Thompson K, Cohen RM (1987b) Cognitive effects of l-deprenyl in Alzheimer's disease. Psychopharmacology 91: 489–495CrossRefPubMedGoogle Scholar
  48. Whishaw IQ, Dunnett SB (1985) Dopamine depletion, stimulation or blockade in the rat disrupts spatial navigation and locomotion dependent upon beacon or distal cues. Behav Brain Res 18: 11–29Google Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • L. Yavich
    • 1
  • J. Sirviö
    • 1
  • E. Heinonen
    • 2
  • P. RiekkinenSr.
    • 1
  1. 1.Department of NeurologyUniversity of KuopioKuopioFinland
  2. 2.Orion CorporationFarmos R&D PharmaceuticalsTurkuFinland

Personalised recommendations